CBD American Shaman Products Revenue and Competitors

Location

N/A

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • CBD American Shaman Products's estimated annual revenue is currently $25.1M per year.(i)
  • CBD American Shaman Products's estimated revenue per employee is $270,000

Employee Data

  • CBD American Shaman Products has 93 Employees.(i)
  • CBD American Shaman Products grew their employee count by -1% last year.

CBD American Shaman Products's People

NameTitleEmail/Phone
1
CEO Reveal Email/Phone
2
Business OwnerReveal Email/Phone
3
Staff AccountantReveal Email/Phone
4
Wholesale Account ManagerReveal Email/Phone
5
Business OwnerReveal Email/Phone
6
Senior TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$25.1M93-1%N/AN/A
Add Company

What Is CBD American Shaman Products?

Our CBD American Shaman line of products contain amazing terpene rich, CBD Hemp Oil. Our line includes the most powerful CBD Hemp Oil Products available. CBD Hemp Oil is made from Industrial Hemp. CBD oil is LEGAL and AVAILABLE in all 50 states. No permit or prescription is required. Every adult U.S. citizen can now benefit from the use of CBD oil! Our CBD American Shaman line of products contain the HIGHEST QUALITY HEMP OIL AVAILABLE containing high amounts of CBD (Cannabidiol) 100% Natural-Pure CO2 Extract. It is 100% Organic, Gluten Free, Non GMO Hemp and has No Heavy Metals or Insecticides. Batch tested using Ultra Performance Convergence Chromatography. Since industrial hemp is still illegal to grow in the US, we import CBD rich industrial hemp paste from Norway where industrial hemp is legally grown and processed. The import process is complex. We must provide samples to the FDA, DEA and Homeland Security for testing. The industrial hemp paste is held in quarantine until all government agencies sign off that the THC levels are within the legal limits (essentially non existent). Once the CBD rich hemp paste is in our possession, we further extract the CBD with ethanol and Ultra Performance Convergence Chromatography. This process uses high pressure CO2 as a solvent to separate the CBD from non active organic compounds in our cGMP lab. This is the same process GW Pharmaceuticals of England uses to extract CBD for use in Sativex, the worlds first prescription pharmaceutical made from cannabis extract. Because we follow these industry standards, our CBD oil is the most effective and of the highest quality on the market today.

keywords:N/A

N/A

Total Funding

93

Number of Employees

$25.1M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CBD American Shaman Products News

2022-04-19 - Cbd-Enhanced Probiotic Supplements Market Size, Outlook And ...

CBD American Shaman, Green Garden Gold, NewLeaf Brands, Kovo Essentials, ... By the product type, the market is primarily split into:.

2022-04-06 - Former Chiefs lineman joins CBD shop for Topeka ribbon cutting

The shop, located at 6032 SW 29th St., sells products made from industrial hemp. Grunhard says products like those sold at American Shaman are...

2022-03-30 - CBD American Shaman Creates First-Of-Its-Kind Immune Boosting ...

CBD American Shaman produces high quality cannabinoid tinctures, creams, pet products and more. CBD American Shaman is certified by the US Hemp...

2021-04-15 - Validcare Announces a Second Cohort of CBD Brands Joins Safety Study to Gather Data for FDA

"We are excited to have our state of the art, decentralized trial technology overcome the hurdles of performing research during a pandemic." DENVER (PRWEB) April 15, 2021 Validcare announced today the addition of a second cohort of CBD brands participating in a large scale, human safety study, ...

2021-03-23 - Validcare’s Clinical Study Reports Preliminary Results of CBD Liver Safety

Our primary endpoint in this study is to observe potential liver effects in adults ingesting oral forms of hemp derived CBD for a minimum of 60 days. What we observed to date is no clinical evidence of liver disease in any participants. DENVER (PRWEB) March 23, 2021 After seven months of clini ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$27.8M11122%N/A
#2
$32.9M1220%N/A
#3
$44.7M166N/AN/A
#4
$19.4M17610%N/A
#5
$35M1774%N/A